Fri, September 23, 2011
[ Fri, Sep 23rd 2011 ]: Market Wire
Tunstall Healthcare Group Limited neemt AMAC over
[ Fri, Sep 23rd 2011 ]: Market Wire
Two Veteran HCA Leaders Get New Responsibilities
[ Fri, Sep 23rd 2011 ]: Market Wire
IPC The Hospitalist Company Named One of FORTUNEa?s a100 Fastest-Growing Companiesa
[ Fri, Sep 23rd 2011 ]: Market Wire
European CHMP Adopts Positive Opinion for Evipler .. Tablet Regimen for the Treatment of HIV Infection
[ Fri, Sep 23rd 2011 ]: Market Wire
MannKind Announces Proposed Offering of Senior Secured Discount Notes Due 2017
[ Fri, Sep 23rd 2011 ]: Market Wire
MISE JOUR RGLEMENTAIRE DE CELGENE AU SUJET DE REVLIMID®
[ Fri, Sep 23rd 2011 ]: Market Wire
Celgene prsentiert aktuelle Informationen zur Marktzulassung von REVLIMID®
[ Fri, Sep 23rd 2011 ]: Market Wire
AGGIORNAMENTO REGOLATORIO DI CELGENE CIRCA REVLIMID®
[ Fri, Sep 23rd 2011 ]: Market Wire
Celgene Regulatory Update on REVLIMID®
Thu, September 22, 2011
[ Thu, Sep 22nd 2011 ]: Market Wire
Adamis Prostate Cancer Drug APC-200 Granted Patents in Singapore and South Africa
[ Thu, Sep 22nd 2011 ]: Market Wire
Dr. Reddya?s Announces the Launch of Rivastigmine Tartrate Capsules
[ Thu, Sep 22nd 2011 ]: Market Wire
Bond Reports Strong Retail Outlet Growth
[ Thu, Sep 22nd 2011 ]: Market Wire
dermaPACE Pivotal Phase III Clinical Trial Data i .. r Healing to Be Presented at Plastic Surgery 2011
[ Thu, Sep 22nd 2011 ]: Market Wire
ARIAD to Present at the Jefferies 2011 Global Healthcare Conference in London
[ Thu, Sep 22nd 2011 ]: Market Wire
Cambridge Heart Announces Agreement to Distribute Its HearTwave II System in Singapore
[ Thu, Sep 22nd 2011 ]: Market Wire
Media Advisory - Oncolytics Biotech®;; .. esent at the JMP Securities Healthcare Conference
[ Thu, Sep 22nd 2011 ]: Market Wire
Columbia Laboratories Extends Stockholder Rights .. rve Use of Net Operating Losses under Section 382
[ Thu, Sep 22nd 2011 ]: Market Wire
The Future of Ablation Therapies Conference
Wed, September 21, 2011
[ Wed, Sep 21st 2011 ]: Market Wire
ACADIA Pharmaceuticals to Present at the Sixth An .. ities Healthcare Conference on September 28, 2011
[ Wed, Sep 21st 2011 ]: Market Wire
Cerus to Present at Jefferies 2011 Global Healthcare Conference on Sept 28, 2011
[ Wed, Sep 21st 2011 ]: Market Wire
InSite Vision to Present at the Sixth Annual JMP Securities Healthcare Conference
[ Wed, Sep 21st 2011 ]: Market Wire
Unigene Divests Non-Core Asset and Focuses Resour .. velopment and Peptide Drug Delivery Opportunities
[ Wed, Sep 21st 2011 ]: Market Wire
ARIAD Announces Start of Enrollment in Phase 1/2 .. 3, an Investigational Dual Inhibitor of ALK and E
[ Wed, Sep 21st 2011 ]: Market Wire
Celgene Corporation to Present at JMP Securities Healthcare Conference 2011
[ Wed, Sep 21st 2011 ]: Market Wire
Independent Proxy Advisory Firms ISS and Glass Le .. hareholders Vote in Favour of Plan of Arrangement
[ Wed, Sep 21st 2011 ]: Market Wire
Smith & Nephew Introduces New Hysteroscopic Morce .. on Simulator Designed to Enhance Surgeon Training
Tue, September 20, 2011
[ Tue, Sep 20th 2011 ]: Market Wire
St. Jude Medical meldt Europese introductie van kleiner quadripolair pacingsysteem
[ Tue, Sep 20th 2011 ]: Market Wire
Exactech Introduces New Material, Efficient Approach for Acetabular Reconstruction
[ Tue, Sep 20th 2011 ]: Market Wire
??????????????,?52???,2???????????????????ONGLYZAa" (????)???????(HbA1c)??
[ Tue, Sep 20th 2011 ]: Market Wire
St. Jude Medical annuncia il lancio in Europa di .. i stimolazione quadripolare di dimensioni ridotte
[ Tue, Sep 20th 2011 ]: Market Wire
Merck Joins Global Fight to Help Save Women's Lives During Pregnancy and Childbirth
[ Tue, Sep 20th 2011 ]: Market Wire
Pfizer Announces Expiration of Subsequent Offerin .. letion of Tender Offer for Shares of Icagen, Inc.
[ Tue, Sep 20th 2011 ]: Market Wire
Centric Health to Acquire Medical Imaging Centres Inc. and Rads 24/7 Teleradiology Consultants
[ Tue, Sep 20th 2011 ]: Market Wire
Covidien to Present at Jefferies 2011 Global Healthcare Conference
Mon, September 19, 2011
[ Mon, Sep 19th 2011 ]: Market Wire
PPD Appoints Raymond Hill as Chief Executive Officer and Member of the Board of Directors
[ Mon, Sep 19th 2011 ]: Market Wire
Wright Medical Group, Inc. Names Robert J. Palmisano President and Chief Executive Officer
[ Mon, Sep 19th 2011 ]: Market Wire
FDA Panel to Review AtriCurea?s Synergy Ablation System on October 26
[ Mon, Sep 19th 2011 ]: Market Wire
Mercka?s ISENTRESS® (raltegravir) in Combination .. y and Tolerability in an Observational Trial in a
[ Mon, Sep 19th 2011 ]: Market Wire
Inhibitex Commences Dosing of Phase 2 Clinical Tr .. of INX-189 in HCV Infected Genotype 2/3 Patients
[ Mon, Sep 19th 2011 ]: Market Wire
ONGLYZAa" (saxagliptin) (saxagliptina) adicionado .. abetes tipo 2 manteve redues nos nveis de acar no
[ Mon, Sep 19th 2011 ]: Market Wire
Extensin de un estudio en fase de investigacin de .. liptina) incorporado a la insulina en adultos con
[ Mon, Sep 19th 2011 ]: Market Wire
Cord Blood America Updates Investors on Laboratory Licensing
Sun, September 18, 2011
[ Sun, Sep 18th 2011 ]: Market Wire
Sangamo BioSciences Announces Presentation of Gro .. a From ZFN Therapeutic for HIV/AIDS at ICAAC 2011
Sat, September 17, 2011
[ Sat, Sep 17th 2011 ]: Market Wire
Prolia® (Denosumab) Phase 2 Extension Study Show .. one Mineral Density Over Eight Years of Treatment
[ Sat, Sep 17th 2011 ]: Market Wire
Dans le cadre de la prolongation d'une ©tude exp .. tine) plus insuline chez les patients adultes att
[ Sat, Sep 17th 2011 ]: Market Wire
Dans le cadre de la prolongation d';&# .. 4;;; ONGLYZAa" (saxagliptine) plus insu
[ Sat, Sep 17th 2011 ]: Market Wire
Dans le cadre de la prolongation d';&# .. e,;;;; ONGLYZAa" (saxagliptine) p
[ Sat, Sep 17th 2011 ]: Market Wire
Dans le cadre de la prolongation d';&# .. ntale,;;;;; ONGLYZAa" (saxagli

Alkermes to Present at Jefferies 2011 Global Healthcare Conference

DUBLIN--([ BUSINESS WIRE ])--[ Alkermes plc ] (NASDAQ: ALKS) announced today that it will present at the Jefferies 2011 Global Healthcare Conference on Wednesday, Sept. 28, 2011, at 12:20 p.m. BST (7:20 a.m. ET) from London. The webcast may be accessed from the investor relations section on [ www.alkermes.com ] and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts and manufacturing facilities in Athlone, Ireland; Gainesville, Georgia; and Wilmington, Ohio. For more information, please visit Alkermesa™ website at [ www.alkermes.com ].